Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations (1 CME)

5 (5 votes)

Earn 1 AMA PRA Category 1 Credit(s)™ while learning more about buprenorphine pharmacology in this journal article from The Journal of Addiction Medicine 2019. Sharon L. Walsh, PhD, Marion A. Coe, BA, Michelle R. Lofwall, MD

Learning objectives: 

1.) Explain how aspects of buprenorphine pharmacology (of both transmucosal and long-acting formulations) manifest its clinical effects

2.) Provide an explanation of the differences in dose exposure provided by the different buprenorphine formulations

3.) Define potency with a clinical example


Key:

Complete
Failed
Available
Locked
Review the journal article
Open to download resource.
Open to download resource. Please review the journal article in it's entirety
Quiz
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass Answer all of the questions
CME Evaluation
13 Questions
13 Questions Complete the CME evaluation to claim CME
CME Certificate
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available 1 AMA PRA Category 1 Credit